Wells Fargo
CPXX

Wells Fargo’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Wells Fargo’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-13,500
Closed -$407K – 6589
2016
Q2 		$407K Buy
13,500
+11,100
+463% +$225K ﹤0.01% 4027
2016
Q1 		$26K Buy
2,400
+200
+9% +$656 ﹤0.01% 5442
2015
Q4 		$4K Hold
2,200
– – ﹤0.01% 5942
2015
Q3 		$4K Buy
+2,200
New +$4.88K ﹤0.01% 5919

Wells Fargo's CPXX Position: Q3 2016 in Review

Wells Fargo sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 13,500 shares — an estimated $407K sold.

Wells Fargo first reported a position in CPXX in Q3 2015 and held it in 4 quarters. The position peaked at $407K in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • Wells Fargo reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • Wells Fargo sold 13,500 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $407K.
  • Wells Fargo first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q3 2015 and held it in 4 quarters.
  • Wells Fargo's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $407K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on Wells Fargo's 13F filing for Q3 2016, filed 31 Oct 2016.